HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-Specific CD8+ T Cells

Journal of Virology

Volumn 86, Issue 7, 2012, Pages 4014-4018

  Mendoza, Daniel ^a   Royce, Cassandra ^a   Ruff, Laura E ^a   Ambrozak, David R ^a   Quigley, Máire F ^a,b   Dang, Thurston ^c   Venturi, Vanessa ^c   Price, David A ^a,b   Douek, Daniel C ^a   Migueles, Stephen A ^a   Connors, Mark ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HLA B57 ANTIGEN; T LYMPHOCYTE RECEPTOR; HLA B ANTIGEN;

ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLONAL VARIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; ANTIGEN MEDIATED CLONAL SELECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE; STATISTICS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

CD8-POSITIVE T-LYMPHOCYTES; CLONAL SELECTION, ANTIGEN-MEDIATED; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HLA-B ANTIGENS; HUMANS; SPECIES SPECIFICITY;

EID: 84861302641     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06982-11     Document Type: Article

References (44)

1. + T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204:2473-2485.
2. + T-cell polyfunctionality and HIV-suppressive activity. Blood 113: 6351-6360.
3. + elite suppressors despite CTL escape mutations. J. Exp. Med. 203:1357-1369.
4. + T lymphocytes. Nature 410:106-111.
5. Davenport MP, Price DA, McMichael AJ. 2007. The T cell repertoire in infection and vaccination: implications for control of persistent viruses. Curr. Opin. Immunol. 19:294-300.
6. Douek DC, et al. 2002. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 168:3099-3104.
7. + T cell responses in HIV-1 and cytomegalovirus infections. Eur. J. Immunol. 32:3756-3764.
8. Flores-Villanueva PO, et al. 2001. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. U. S. A. 98:5140-5145.
9. + T-cell responses are involved in durable control of AIDS virus replication. J. Virol. 81:3465-3476.
10. Gillespie GM, et al. 2006. Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection. J. Immunol. 177:3893-3902.
11. Goulder PJ, et al. 1996. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res. Hum. Retroviruses 12:1691-1698.
12. Han Y, et al. 2008. The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors. AIDS 22:541-544.
13. + T-cell response associated with immunologic control. Curr. Opin. HIV AIDS 6:169-173.
14. + T-cells is a correlate of HIV elite control. PLoS Pathog. 6:e1000917.
15. + T-cell clonotypes by HIV. Blood 118:2138-2149.
16. + T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness. J. Virol. 83:2728-2742.
17. Kalams SA, et al. 1996. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J. Exp. Med. 183:1669-1679.
18. Kalams SA, et al. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
19. Kloosterboer N, et al. 2005. Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus. Virology 339:70-80.
20. Kosmrlj A, et al. 2010. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 465:350-354.
21. Lambotte O, et al. 2005. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin. Infect. Dis. 41:1053-1056.
22. + T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation. PLoS One 2:e1152.
23. + TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. J. Immunol. 171:307-316.
24. + T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. Blood 107:2373-2383.
25. Migueles SA, Connors M. 2010. Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. JAMA 304:194-201.
26. + longterm nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J. Virol. 77:6889-6898.
27. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068.
28. + T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29:1009-1021.
29. Migueles SA, et al. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. U. S. A. 97:2709-2714.
30. + T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J. Virol. 83:11876-11889.
31. Miura T, et al. 2009. HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers. J. Virol. 83:3407-3412.
32. Papagno L, et al. 2002. Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin. Exp. Immunol. 130:509-517.
33. Pereyra F, et al. 2008. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197:563-571.
34. + T cell responses in SIV infection. J. Exp. Med. 206:923-936.
35. + T cell populations specific for persistent DNA viruses. J. Exp. Med. 202:1349-1361.
36. Quigley MF, Almeida JR, Price DA, Douek DC. 2011. Unbiased molecular analysis of T cell receptor expression using template-switch anchored RT-PCR, p 10.33.1-10.33.16. In Coligan JE, et al (ed), Current protocols in immunology. John Wiley and Sons, New York, NY.
37. + T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. U. S. A. 104:6776-6781.
38. Simons BC, et al. 2008. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants. J. Immunol. 181:5137-5146.
39. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. 2006. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6:883-894.
40. + T cell response. J. Immunol. 186:359-371.
41. Venturi V, Kedzierska K, Turner SJ, Doherty PC, Davenport MP. 2007. Methods for comparing the diversity of samples of the T cell receptor repertoire. J. Immunol. Methods 321:182-195.
42. Venturi V, et al. 2011. A mechanism for TCR sharing between T cell subsets and individuals revealed by pyrosequencing. J. Immunol. 186: 4285-4294.
43. Yant LJ, et al. 2006. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 80:5074-5077.
44. Yu XG, et al. 2007. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J. Virol. 81:1619-1631.